Richard M Hoetelmans
Overview
Explore the profile of Richard M Hoetelmans including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sekar V, Lefebvre E, De Pauw M, Vangeneugden T, Hoetelmans R
Br J Clin Pharmacol
. 2008 May;
66(2):215-21.
PMID: 18460033
Aims: To investigate the interaction between ketoconazole and darunavir (alone and in combination with low-dose ritonavir), in HIV-healthy volunteers. Methods: Volunteers received darunavir 400 mg bid and darunavir 400 mg...
2.
Scholler-Gyure M, Kakuda T, Sekar V, Woodfall B, de Smedt G, Lefebvre E, et al.
Antivir Ther
. 2007 Aug;
12(5):789-96.
PMID: 17713162
Objective: To evaluate the pharmacokinetics of TMC125 (etravirine) and darunavir (DRV) with low-dose ritonavir (DRV/r). Design: Open-label, randomized, two-way crossover Phase I trial. Methods: Thirty-two HIV-negative volunteers were randomized 1:1...
3.
Antinori A, Perno C, Giancola M, Forbici F, Ippolito G, Hoetelmans R, et al.
Clin Infect Dis
. 2005 Nov;
41(12):1787-93.
PMID: 16288405
Background: Cerebrospinal fluid (CSF) concentrations of multiple drugs in a large human immunodeficiency virus (HIV)-infected patient population, the virtual phenotype profiles for HIV in the plasma and CSF compartments, and...
4.
De Luca A, Baldini F, Cingolani A, Di Giambenedetto S, Hoetelmans R, Cauda R
J Acquir Immune Defic Syndr
. 2004 Apr;
35(4):359-66.
PMID: 15097152
The safety, efficacy, and mutual interactions of combination amprenavir with lopinavir/ritonavir as deep salvage treatment were investigated in a prospective 24-week pilot study. HIV-infected patients (n = 22) with virologic...
5.
Cardiello P, van Heeswijk R, Hassink E, Srasuebkul P, Mahanontharit A, Samor T, et al.
J Acquir Immune Defic Syndr
. 2002 May;
29(5):464-70.
PMID: 11981362
Objective: To determine the feasibility of switching therapy for HIV-1-infected patients with plasma viral loads of <50 HIV-1 RNA copies/mL who are receiving twice-daily saquinavir soft-gelatin capsules (SQV-SGC) plus dual...